Teva is currently involved in patent litigation with Wyeth concerning this product in the US District Court of New Jersey.
In September 2007, the district court denied a motion filed by Wyeth for a preliminary injunction related to Teva’s pantoprazole tablets. In that decision, the court found that Wyeth did not meet its burden of proving likelihood of success on the merits. Wyeth has appealed that decision.